Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
KRAS: Reasons for optimism in lung cancer
HTML
PDF
Details
Locations
Year:
2018
Type:
review
Source:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.05.001
Authors:
C.R. Lindsay,
M. Jamal-Hanjani,
M. Forster,
F. Blackhall
Institutions:
Cancer Research UK,
University of Manchester,
The Christie NHS Foundation Trust,
CRUK Lung Cancer Centre of Excellence,
University College London
Language:
English
Topic:
Lung Cancer Treatments and Mutations
Subfield:
Pulmonary and Respiratory Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
KRAS mutation,
non-small cell lung cancer,
KRAS G12C,
STK33,
synthetic lethality,
prognostic factors,
predictive biomarkers
show all 7
SDG:
Good health and well-being
Open Access status:
green
Funders:
Pfizer,
AstraZeneca,
Cancer Research UK,
National Institute for Health and Care Research,
Rosetrees Trust
Awards:
G3145938144,
G6676992503,
G6923477830,
G8175362151
OpenAlex ID:
W2805661833
FWCI:
1.508
Cites:
73
Cited by:
54
Related to:
10